Daniel Bär

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 231 citations · Full text

Regenerative Medicine, Cell Therapy, Transplantation +7

The effect of metabolic comorbidities and commonly used drugs on the prognosis of patients with ovarian cancer

Daniel Bär, Ofer Lavie, Nili Stein et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 2016 · 42 citations

Oncology, Cancer Epidemiology, Medicine +10

Process improvements with innovative technologies in the starch and sugar industries

Florence Lutin, Mathieu Bailly, Daniel Bär · Desalination · 2002 · 36 citations

Biomanufacturing, Sugar Industries, Food Innovation +10

Rituximab biosimilar RTXM83 versus reference rituximab in combination with CHOP as first-line treatment for diffuse large B-cell lymphoma: a randomized, double-blind study

Myrna Candelaria, Derlis Gonzalez, Márcia Torresan Delamain et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2019 · 32 citations · Full text

Skeletal involvement in Gaucher disease: An observational multicenter study of prognostic factors in the Argentine Gaucher disease patients

Guillermo Drelichman, Nicolas Fernández Escobar, Nora Basack et al. · American Journal of Hematology · 2016 · 18 citations

Prognostic Factors, Rheumatology, Bone Tgs +15